Currently predicting for Thu, 2 May 2024

Trading levels for INCY

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 55.07 4.03 %
R2 54.25 2.47 %
R1 53.74 1.51 %
Current price: 52.94
Support S1 52.09 -1.61 %
S2 51.58 -2.57 %
S3 50.75 -4.13 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 59.34 12.09 %
R2 58.37 10.26 %
R1 57.34 8.31 %
Current price 52.94
Support S1 52.56 -0.718%
S2 52.05 -1.68%
S3 51.65 -2.44%

INCY Predictions History

4 months ago
AlexVel predicted that INCY for 2023-12-12 is going $56.89 (-8.03%)

1 year ago
RKP predicted that INCY for 2023-03-23 is going $77.00 (6.56%)

1 year ago
RKP predicted that INCY for 2023-03-22 is going $75.00 (3.79%)

1 year ago
RKP predicted that INCY for 2023-03-21 is going $75.00 (2.05%)

3 years ago
JS predicted that INCY for 2020-08-26 is going $95.96 (2.36%)

3 years ago
iHustle84 predicted that INCY for 2020-08-26 is going $94.67 (0.98%)

3 years ago
2poJeff predicted that INCY for 2020-08-26 is going $94.55 (-0.80%)

3 years ago
JS predicted that INCY for 2020-08-03 is going $98.37 (-3.36%)

3 years ago
iHustle84 predicted that INCY for 2020-08-03 is going $97.67 (-1.10%)

3 years ago
sander7100 yo bro predicted that INCY for 2020-08-03 is going $108.68 (10.04%)

Click to get the best stock tips daily for free!

About Incyte Corporation

Incyte Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as oncogenic drivers in various liquid and solid tumor types; and ICLUSIG, a kinase inhibitor to treat chr... INCY Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT